2024
Transplantation: platform to study recurrence of disease
Burke G, Mitrofanova A, Fontanella A, Vendrame F, Ciancio G, Vianna R, Roth D, Ruiz P, Abitbol C, Chandar J, Merscher S, Pugliese A, Fornoni A. Transplantation: platform to study recurrence of disease. Frontiers In Immunology 2024, 15: 1354101. PMID: 38495894, PMCID: PMC10940352, DOI: 10.3389/fimmu.2024.1354101.Peer-Reviewed Original ResearchMeSH KeywordsGlomerulosclerosis, Focal SegmentalHumansKidney Failure, ChronicKidney TransplantationNeoplasm Recurrence, LocalTransplants
1997
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60
Xenos E, Ciancio G, Burke G, Roth D, Miller J. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Clinical Transplantation 1997, 11: 497-499. PMID: 9361949, DOI: 10.1111/j.1399-0012.1997.tb01032.x.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAge FactorsAgedAzathioprineCadaverCyclosporineFemaleGlucocorticoidsGraft RejectionHumansImmunosuppressive AgentsInfusions, IntravenousKidney Failure, ChronicKidney TransplantationMaleMethylprednisoloneMiddle AgedMuromonab-CD3Mycophenolic AcidTacrolimusTreatment OutcomeConceptsMaintenance immunosuppressionOutcome of kidney transplantationTacrolimus-based therapyMaintenance immunosuppressive regimensEnd-stage renal diseaseImmediate postoperative periodCadaveric transplant recipientsRate of rejectionAntilymphocyte preparationsImmunosuppressive regimensInduction regimenMycophenolate mofetilRescue therapyRenal recipientsTransplant recipientsRenal transplantationAntibody inductionPostoperative periodTreatment optionsKidney transplantationTacrolimusRenal diseaseRS-61443MycophenolateAge groups